PubMed

Pramlintide reduces postprandial glucose excursions when added to regular insulin or insulin lispro in subjects with type 1 diabetes: a dose-timing study.

Weyer C, Gottlieb A, Kim DD, Lutz K, Schwartz S, Gutierrez M, Wang Y, Ruggles JA, Kolterman OG, Maggs DG.

Diabetes Care. 2003 Nov;26(11):3074-9.PMID: 14578242 [PubMed - indexed for MEDLINE]Related articlesFree article

Pramlintide reduces postprandial glucose excursions when added to insulin lispro in subjects with type 2 diabetes: a dose-timing study.

Maggs DG, Fineman M, Kornstein J, Burrell T, Schwartz S, Wang Y, Ruggles JA, Kolterman OG, Weyer C.

Diabetes Metab Res Rev. 2004 Jan-Feb;20(1):55-60.PMID: 14737746 [PubMed - indexed for MEDLINE]Related articles

Impact of pramlintide on glucose fluctuations and postprandial glucose, glucagon, and triglyceride excursions among patients with type 1 diabetes intensively treated with insulin pumps.

Levetan C, Want LL, Weyer C, Strobel SA, Crean J, Wang Y, Maggs DG, Kolterman OG, Chandran M, Mudaliar SR, Henry RR.

Diabetes Care. 2003 Jan;26(1):1-8.PMID: 12502651 [PubMed - indexed for MEDLINE]Related articlesFree article

Pramlintide lowered glucose excursions and was well-tolerated in adolescents with type 1 diabetes: results from a randomized, single-blind, placebo-controlled, crossover study.

Chase HP, Lutz K, Pencek R, Zhang B, Porter L.

J Pediatr. 2009 Sep;155(3):369-73. Epub 2009 May 21.PMID: 19464026 [PubMed - indexed for MEDLINE]Related articles

Effects of pramlintide on postprandial glucose excursions and measures of oxidative stress in patients with type 1 diabetes.

Ceriello A, Piconi L, Quagliaro L, Wang Y, Schnabel CA, Ruggles JA, Gloster MA, Maggs DG, Weyer C.

Diabetes Care. 2005 Mar;28(3):632-7.PMID: 15735200 [PubMed - indexed for MEDLINE]Related articlesFree article

Control of postprandial plasma glucose by an oral insulin product (HIM2) in patients with type 2 diabetes.

Kipnes M, Dandona P, Tripathy D, Still JG, Kosutic G.

Diabetes Care. 2003 Feb;26(2):421-6.PMID: 12547873 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of 14 days' subcutaneous administration of the human amylin analogue, pramlintide (AC137), on an intravenous insulin challenge and response to a standard liquid meal in patients with IDDM.

Kolterman OG, Schwartz S, Corder C, Levy B, Klaff L, Peterson J, Gottlieb A.

Diabetologia. 1996 Apr;39(4):492-9.PMID: 8778001 [PubMed - indexed for MEDLINE]Related articles

The human amylin analog, pramlintide, reduces postprandial hyperglucagonemia in patients with type 2 diabetes mellitus.

Fineman M, Weyer C, Maggs DG, Strobel S, Kolterman OG.

Horm Metab Res. 2002 Sep;34(9):504-8.PMID: 12384827 [PubMed - indexed for MEDLINE]Related articles

Optimal administration of lispro insulin in hyperglycemic type 1 diabetes.

Rassam AG, Zeise TM, Burge MR, Schade DS.

Diabetes Care. 1999 Jan;22(1):133-6.PMID: 10333914 [PubMed - indexed for MEDLINE]Related articlesFree article

Postprandial insulin lispro. A new therapeutic option for type 1 diabetic patients.

Schernthaner G, Wein W, Sandholzer K, Equiluz-Bruck S, Bates PC, Birkett MA.

Diabetes Care. 1998 Apr;21(4):570-3.PMID: 9571344 [PubMed - indexed for MEDLINE]Related articlesFree article

Improved postprandial glycemic control with Humalog Mix75/25 after a standard test meal in patients with type 2 diabetes mellitus.

Malone JK, Woodworth JR, Arora V, Yang H, Campaigne BN, Hallé JP, Yale JF, Grossman LD.

Clin Ther. 2000 Feb;22(2):222-30.PMID: 10743981 [PubMed - indexed for MEDLINE]Related articles

The effect of the insulin analog lispro on nighttime blood glucose control in type 1 diabetic patients.

Ahmed AB, Home PD.

Diabetes Care. 1998 Jan;21(1):32-7.PMID: 9538967 [PubMed - indexed for MEDLINE]Related articlesFree article

Optimal provision of daytime NPH insulin in patients using the insulin analog lispro.

Ahmed AB, Home PD.

Diabetes Care. 1998 Oct;21(10):1707-13.PMID: 9773735 [PubMed - indexed for MEDLINE]Related articlesFree article

Reducing postprandial hyperglycemia with adjuvant premeal pramlintide and postmeal insulin in children with type 1 diabetes mellitus.

Hassan K, Heptulla RA.

Pediatr Diabetes. 2009 Jun;10(4):264-8. Epub 2008 Dec 18.PMID: 19140902 [PubMed - indexed for MEDLINE]Related articles

The role of prandial pramlintide in the treatment of adolescents with type 1 diabetes.

Rodriguez LM, Mason KJ, Haymond MW, Heptulla RA.

Pediatr Res. 2007 Dec;62(6):746-9.PMID: 17957149 [PubMed - indexed for MEDLINE]Related articles

The role of amylin and glucagon in the dampening of glycemic excursions in children with type 1 diabetes.

Heptulla RA, Rodriguez LM, Bomgaars L, Haymond MW.

Diabetes. 2005 Apr;54(4):1100-7.PMID: 15793249 [PubMed - indexed for MEDLINE]Related articlesFree article

Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.

Pampanelli S, Torlone E, Ialli C, Del Sindaco P, Ciofetta M, Lepore M, Bartocci L, Brunetti P, Bolli GB.

Diabetes Care. 1995 Nov;18(11):1452-9.PMID: 8722069 [PubMed - indexed for MEDLINE]Related articles

Optimization of evening insulin dose in patients using the short-acting insulin analog lispro.

Ahmed AB, Mallias J, Home PD.

Diabetes Care. 1998 Jul;21(7):1162-6.PMID: 9653613 [PubMed - indexed for MEDLINE]Related articlesFree article

Insulin lispro lowers postprandial glucose in prepubertal children with diabetes.

Deeb LC, Holcombe JH, Brunelle R, Zalani S, Brink S, Jenner M, Kitson H, Perlman K, Spencer M.

Pediatrics. 2001 Nov;108(5):1175-9.PMID: 11694699 [PubMed - indexed for MEDLINE]Related articlesFree article

The human amylin analog, pramlintide, corrects postprandial hyperglucagonemia in patients with type 1 diabetes.

Fineman MS, Koda JE, Shen LZ, Strobel SA, Maggs DG, Weyer C, Kolterman OG.

Metabolism. 2002 May;51(5):636-41.PMID: 11979398 [PubMed - indexed for MEDLINE]Related articles